Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.58 |
| ▸ | TP53 | P04637 | 1/20 | 0.58 |
| ▸ | ACACB | O00763 | 3/20 | 0.47 |
| ▸ | RECQL | P46063 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
| ▸ | EBP | Q15125 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.44 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.44 |
| ▸ | COPS5 | Q92905 | 1/20 | 0.42 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.42 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.40 |
| ▸ | REN | P00797 | 1/20 | 0.40 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.40 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18253225 | 1.00 | TSHR (0.58) | TSHRTP53ACACBRECQLLMNA | |
| SCHEMBL41070 | 0.87 | ESR1 (0.44) | TSHRTP53ACACB | |
| SCHEMBL113650 | 0.85 | TP53 (0.56) | TSHRTP53ACACBRECQLLMNA | |
| SCHEMBL8338248 | 0.83 | TP53 (0.55) | TSHRTP53ACACBRECQLLMNA | |
| SCHEMBL196800 | 0.83 | TAAR1 (0.48) | TSHRLMNA | |
| SCHEMBL547420 | 0.82 | TSHR (0.62) | TSHRTP53ACACBLMNAEBP | |
| SCHEMBL19646258 | 0.82 | ADORA3 (0.48) | TSHRTP53ACACBLMNAKCNH2 | |
| SCHEMBL3200869 | 0.82 | ESR1 (0.41) | TSHRTP53ACACB | |
| SCHEMBL25124242 | 0.81 | TP53 (0.52) | TSHRTP53ACACBRECQLLMNA | |
| SCHEMBL2423098 | 0.81 | ALDH1A1 (0.47) | EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10053472-B2 | Silicon-based fungicides and process for producing the same | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2018-08-21 | — | — | US | disclosed |
| EP-3089985-B1 | SILICON-BASED FUNGICIDES AND PROCESS FOR PRODUCING THE SAME | COUNCIL SCIENT IND RES (IN) | 2018-06-27 | — | — | EP | disclosed |
| US-20160326190-A1 | SILICON-BASED FUNGICIDES AND PROCESS FOR PRODUCING THE SAME | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2016-11-10 | — | — | US | disclosed |
| EP-3089985-A1 | SILICON-BASED FUNGICIDES AND PROCESS FOR PRODUCING THE SAME | Council of Scientific and Industrial Research (IN) | 2016-11-09 | — | — | EP | disclosed |
| WO-2015102025-A1 | SILICON-BASED FUNGICIDES AND PROCESS FOR PRODUCING THE SAME | COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) | 2015-07-09 | — | — | WO | disclosed |
| US-5733755-A | Method for the enantioselective synthesis of chiral derivatives of S-3-(4'-t | INDUSTRIE CHIMICHE CAPPARO S.P.A. (IT) | 1998-03-31 | — | — | US | disclosed |
| EP-0775683-A1 | Method for the enantioselective synthesis of chiral derivatives of S-3-(4'-Tert-Butyl)-Phenyl-2-Methyl propylamine, systemic fungicides | INDUSTRIE CHIMICHE CAFFARO S.p.A. (IT) | 1997-05-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160326190-A1 | SILICON-BASED FUNGICIDES AND PROCESS FOR PRODUCING THE SAME | CYP51A1, STS, LSS | TSHR 4530/4885TP53 2777/4885ACACB 3925/4885 |
| US-10053472-B2 | Silicon-based fungicides and process for producing the same | CYP51A1, STS, LSS | TSHR 4530/4885TP53 2777/4885ACACB 3925/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.